Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
Top Research Reports for Johnson & Johnson, Walt Disney & NextEra Energy
07:51pm, Wednesday, 25'th May 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), The Walt Disney Company (DIS) and NextEra Energy, Inc. (NEE).
3 Recession-Proof Stocks To Protect Your Portfolio From Fed-Induced Turmoil
09:38am, Wednesday, 25'th May 2022 Investing.com
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot
06:48pm, Tuesday, 24'th May 2022 Zacks Investment Research
AstraZeneca's (AZN) third/booster dose of its COVID-19 vaccine gets authorized in Europe for use in adults, both for homologous and heterologous use.
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot
03:48pm, Tuesday, 24'th May 2022
AstraZeneca's (AZN) third/booster dose of its COVID-19 vaccine gets authorized in Europe for use in adults, both for homologous and heterologous use.
Eli Lilly and AstraZeneca Are the Lowest Spenders on Dividends, Buybacks
11:03am, Tuesday, 24'th May 2022
Share buybacks and dividends among large drug makers reached a five-year high in 2021 as spending climbed to about $110 billion, according to an analysis by pharma consulting group Evaluate Vantage.
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
10:17am, Monday, 23'rd May 2022
Innoviva Inc (NASDAQ: INVA) has agreed to acquire Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) at $2.20 per share in cash. Innoviva currently owns approximately 60% of the outstanding shar
AstraZeneca Chairman: Making vaccines is one thing, but we need to make sure they get distributed
08:31am, Monday, 23'rd May 2022
AstraZeneca Chairman Leif Johansson talks to Geoff Cutmore and Steve Sedgwick about what we can learn from the Covid pandemic ahead of the next pandemic.
AstraZeneca's Covid-19 vaccine gets EU approval for third doses
02:40am, Monday, 23'rd May 2022
By Jaime Llinares Taboada
AstraZeneca (AZN) Inks Deal to Develop COVID-19 Antibodies
04:33pm, Wednesday, 18'th May 2022
AstraZeneca (AZN) partners with a U.K.-based biotech company to develop monoclonal antibodies targeting the COVID-causing virus.
5 Stocks to Buy for the Coming Recession
11:51am, Wednesday, 18'th May 2022
Each of these stocks to buy are low-beta stocks with attractive dividend yields to help endure a recession. The post 5 Stocks to Buy for the Coming Recession appeared first on InvestorPlace.
If stagflation emerges, buy AstraZeneca and Reckitt, avoid Aviva and BP says analyst
11:51am, Wednesday, 18'th May 2022
The looming spectre of stagflation, the process where an economy is dogged by both low growth and high inflation and unemployment, is awakening like an embalmed mummy after a deep slumber. Although th
Is This Vaccine Stock in Trouble -- or Ready for a Rebound?
06:00am, Friday, 13'th May 2022
Inovio may be at a turning point.
Biopharma Stock Could Soon Break Higher
02:00pm, Tuesday, 10'th May 2022
Biopharmaceutical stock AstraZeneca PLC (NASDAQ:AZN) settled around the $64.52 level on Friday, which also marks its $200 billion market cap as well as two prior highs in November 2021 and July 2020.
3 Top Biotech Stocks to Buy Right Now
10:45am, Friday, 06'th May 2022
These three pharma stocks each pay market-beating dividends to shareholders.
3 Nasdaq 100 Stocks to Buy Hand Over Fist in May
05:06am, Friday, 06'th May 2022
These fast-paced stocks are plain-as-day bargains.
